Patient Online Report of Selective Serotonin Reuptake Inhibitor-Induced Persistent Postwithdrawal Anxiety and Mood Disorders
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Paroxetine and fluoxetine are both metabolised by cytochrome P450 2D6 and inhibit their own metabolism, resulting in non-linear kinetics 74 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [74]
In the citing paper
“Two of the included studies indicate that in particular long-term paroxetine use may carry an increased risk of PAWS (Belaise et al., 2012; Fava et al., 2007)”
From Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis (2025) · cites this paper as Belaise et al., 2012
In the citing paper
“Belaise et al. (2012) reported that patients self-identifying with antidepressant withdrawal syndrome exhibited predominantly very severe symptoms that significantly impaired their quality of life.”
From Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis (2025) · cites this paper as Belaise et al., 2012
In the citing paper
“One analysis of online self-reports (Belaise et al., 2012) reported a mean duration of 2.5 years, with a range of 0.1 to 6 years.”
From Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis (2025) · cites this paper as Belaise et al., 2012
In the citing paper
“Three studies (Belaise et al., 2012; Hengartner et al., 2020; Stockmann et al., 2018) were based on self-reported information posted online in peer-support groups on the Internet, such as SurvivingAntidepressants.org, by people self-identifying with an antidepressant withdrawal syndrome.”
From Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis (2025) · cites this paper as Belaise et al., 2012
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
Discontinuation Symptoms After Treatment With Serotonin Reuptake Inhibitors: A Literature Review
Zajecka, J., Tracy, K. A., & Mitchell, S. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0702 · Cited by 209
Schifano, F., D’Offizi, S., Piccione, M., Corazza, O., Deluca, P., Davey, Z., Di Melchiorre, G., Di Furia, L., Farré, M., Flesland, L., et al. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000321079 · Cited by 187
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.7.848 · Cited by 176
Self-citationChouinard, G., & Chouinard, V.-A. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000112883 · Cited by 168
Self-citationSevere cases of neuroleptic-induced supersensitivity psychosis
Chouinard, G. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90050-2 · Cited by 123
Self-citationFava, G. A., Bernardi, M., Tomba, E., & Rafanelli, C. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007462 · Cited by 80
Differential Efficacy of Unilateral and Bilateral ECT
FONTAINE, R., & YOUNG, T. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.8.1013-b · Cited by 62
(2006) · PubMed · Cited by 33
Self-citationDiscontinuing Paroxetine: A Personal Account
Shoenberger, D. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000063650 · Cited by 12
Cited by
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Self-citationAntidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Tapering of SSRI treatment to mitigate withdrawal symptoms
Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30032-x · Cited by 280
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477313 · Cited by 270
Self-citationAcute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Self-citationOffidani, E., Guidi, J., Tomba, E., & Fava, G. A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000353198 · Cited by 166
New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164
Self-citationRead, J., Cartwright, C., & Gibson, K. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.01.042 · Cited by 150
“’ Nevertheless it seems that, for some people, there are also additional, quite real withdrawal effects (Belaise et al., 2012), and that these can contribute to a decision to go back on the medication.”
BackgroundGolder, S., Norman, G., & Loke, Y. K. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12746 · Cited by 113
Antidepressant Withdrawal and Rebound Phenomena
Henssler, J., Heinz, A., Brandt, L., & Bschor, T. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0355 · Cited by 50
Rational Use of Antidepressant Drugs
Fava, G. A. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000362803 · Cited by 95
Lerner, A., & Klein, M. (2019) · Brain Communications · doi:10.1093/braincomms/fcz025 · Cited by 89
Antipsychotic maintenance treatment: time to rethink
Moncrieff, J. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001861 · Cited by 80
Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320980573 · Cited by 74
Hengartner, M. P. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320921694 · Cited by 72
Framer, A. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321991274 · Cited by 73
White, E., Read, J., & Julo, S. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320981174 · Cited by 63
SSRI and SNRI withdrawal symptoms reported on an internet forum
Stockmann, T., Odegbaro, D., Timimi, S., & Moncrieff, J. (2018) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-180018 · Cited by 54
Belaise, C., Gatti, A., Chouinard, V.-A., & Chouinard, G. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000362317 · Cited by 44
Self-citationInnovative trends in the design of therapeutic trials in psychopharmacology and psychotherapy
Fava, G. A., Tomba, E., & Tossani, E. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.014 · Cited by 41
“Examples may be provided by switching into a bipolar course, affective lability persisting long time after discontinuation of paroxetine, and generalized unresponsiveness after switching and augmentation with antidepressant drugs (Belaise et al., 2012; Fava and Offidani, 2011).”
Quagliato, L. A., Cosci, F., Shader, R. I., Silberman, E. K., Starcevic, V., Balon, R., Dubovsky, S. L., Salzman, C., Krystal, J. H., Weintraub, S. J., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119859372 · Cited by 35
“However, withdrawal reactions may ensue with either BZs or SSRIs (Belaise et al., 2012; Bhanji et al., 2006; Fava, 2006; Fava et al., 2015; Greenblatt et al., 1990; Nardi et al., 2010; Nielsen et al., 2012; Rickels et al., 1990; Schweizer et al., 1990).”
BackgroundUsui, M., Aramaki, E., Iwao, T., Wakamiya, S., Sakamoto, T., & Mochizuki, M. (2018) · JMIR Medical Informatics · doi:10.2196/11021 · Cited by 31
“For example, analysis of the content of comments posted on patients’ online community pages revealed unknown long-term symptoms of antidepressant withdrawal [10].”
BackgroundEmerging clinical trends and perspectives on comorbid patterns of mental disorders in research
Fava, G. A., Tossani, E., Bech, P., Berrocal, C., Chouinard, G., Csillag, C., Wittchen, H., & Rief, W. (2014) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1412 · Cited by 31
“The drug mostly implicated has been paroxetine (Fava and Offidani, 2011; Belaise et al., 2012).”
BackgroundSelf-citationRead, J., Moncrieff, J., & Horowitz, M. A. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.03.013 · Cited by 30
The need for antidepressant withdrawal support services: Recommendations from 708 patients
Read, J., Lewis, S., Horowitz, M., & Moncrieff, J. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115303 · Cited by 24
“Forum posts have been used to estimate longevity and time of onset of withdrawal from antidepressants (Stockmann et al., 2018) and instances of drug-induced withdrawal anxiety and mood disorders (Belaise et al., 2012).”
BackgroundCartwright, C., Gibson, K., & Read, J. (2018) · Clinical Psychologist · doi:10.1111/cp.12093 · Cited by 20
Scholten, W., Batelaan, N. M., van Oppen, P., Smit, J. H., & van Balkom, A. J. L. M. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000350450 · Cited by 12
Treatment of Comorbid Anxiety Disorders and Depression
Fava, G. A., & Tomba, E. (2014) · The Wiley Handbook of Anxiety Disorders · doi:10.1002/9781118775349.ch53 · Cited by 10
False Beliefs in Academic Psychiatry: The Case of Antidepressant Drugs
Hengartner, M. P., & Plöderl, M. (2018) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.20.1.6 · Cited by 10
“, 1998), are a major medical concern, since so many patients seriously suffer from antidepressant withdrawal for months and even years (Belaise et al., 2012; Fava et al., 2015).”
BackgroundCohen, D., & Recalt, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320964097 · Cited by 15
Rennwald, A., & Hengartner, M. P. (2025) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579602500023x · Cited by 8
“Belaise et al. (2012) noted that PAWS may last several months when the antidepressant drug is not restarted.”
InfluentialWell-Being Therapy in Anxiety Disorders
Cosci, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9705-0_24 · Cited by 5
Hunter, N. (2013) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.15.3.160 · Cited by 5
“…concentrate, tinnitus, dizziness, anxiety, mood swings, insomnia, poor stress tolerance, impaired concentration and memory (Belaise et al., 2012); and postwithdrawal disorders, such as anxiety disorders, panic attacks, tardive insomnia, major depression, and bipolar disorder (Belaise et al., 2012).”
BackgroundInfluentialFava, G. A., Cosci, F., Montiel, C. B., & Tomba, E. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000495967 · Cited by 4
Strayhorn, J. M. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.03.015 · Cited by 5
Hughes, S., Lacasse, J. R., & Spaulding‐Givens, J. (2019) · Qualitative Social Work · doi:10.1177/1473325019868292 · Cited by 2
Fava, G. A. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-76050-1.00017-9
Kaufmann, M., & Lehmann, P. (2019) · NeuroTransmitter · doi:10.1007/s15016-019-6915-1
Basic Study on Automated Extraction of Symptom Related Words from Patient Complaints (Preprint)Preprint
Usui, M., Aramaki, E., Iwao, T., Wakamiya, S., Sakamoto, T., & Mochizuki, M. (2018) · doi:10.2196/preprints.11021
Gründer, G. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21199-7.00002-7
Le contexte de l’arrêt guidé des antidépresseurs
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00006-6
Les manifestations cliniques du sevrage après arrêt des antidépresseurs
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00002-9
First-Person Psychopharmacology: This is Normal Care
Framer, A. (2025) · Journal of Humanistic Psychology · doi:10.1177/00221678251388297
Sharma, R., & Dutta, U. (2026) · Annals of Indian Psychiatry · doi:10.4103/aip.aip_262_25
Why did antidepressant deprescribing fail? A scoping review of contributing factors
Ayed, E., Gerard, E., Quindroit, P., Martino, C. D., Lamer, A., Bubrovszky, M., Baran, J., Calafiore, M., Standaert‐Vitse, A., & Beuscart, J. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-115482
Metadata
- Authors
- Belaise, C., Gatti, A., Chouinard, V.-A., & Chouinard, G.
- Affiliations
- University of Bologna (IT)
- Harvard University (US)
- McGill University (CA)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2012
- Volume
- 81
- Issue
- 6
- Pages
- 386-388
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2044292628
- Cited by
- 45
- References
- 10
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 2 · 2021: 2 · 2020: 5 · 2019: 8 · 2018: 5 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 4 · 2012: 1
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- selective serotonin reuptake inhibitors, persistent anxiety, mood disorders, antidepressant discontinuation, patient-reported outcomes
- MeSH terms
- Anxiety Disorders, Female, Humans, Male, Substance Withdrawal Syndrome, Selective Serotonin Reuptake Inhibitors, Mood Disorders, Internet, Self Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.